One suggested explanation for the increased height of children at the onset of T1DM, or “accelerator” hypothesis [1, 30], involves the insulinopenia in the prediabetic phase that results in increased IGFBP-3 proteolysis, with a subsequent rise in the availability of IGF-I [10]. The gene discussed is IGFBP3; the disease is type 1 diabetes mellitus.